# Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAH

> **NCT07667673** · — · ACTIVE_NOT_RECRUITING · sponsor: **Istanbul University - Cerrahpasa** · enrollment: 50 (estimated)

## Conditions studied

- Pulmonary Hypertension
- Pulmonary Arterial Hypertension
- Right Ventricular Function

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07667673
- **Lead sponsor:** Istanbul University - Cerrahpasa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-05-11
- **Primary completion:** 2027-02
- **Final completion:** 2027-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07667673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07667673, "Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAH". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07667673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*